Overview
Cholangiocarcinoma is a heterogeneous group of neoplasms, which has a rising worldwide incidence. Therefore, it is now a major cause of cancer mortality. Diagnosis, staging, treatment approaches and outcomes differ significantly based on the location of the tumor. Given the challenges of remaining up-to-date in a rapidly expanding field, the aim of this monograph is to provide a comprehensive, fully referenced presentation of the state-of-the-art medical and surgical aspects relevant to the management of cholangiocarcinoma divided by the site of origin (i.e. intrahepatic, hilar and distal). The division of the book into these sections reflects the biological and clinical differences between these tumor types and will permit the authors to address the diagnostic, interventional or treatment issues specific to each tumor type. By presenting all medical and surgical aspects of cholangiocarcinoma in a systematic manner, this monograph will be a ready-to-use instrument for those interested in cholangiocarcinoma, including practicing physicians, residents, fellows and specialists. A list of 66 world-renowned experts contributed to the book, offering the readers the unique opportunity to have a broad perspective on these diseases, practical indications on patient selection and treatment that can be easily applied to both Eastern and Western clinical settings.
Full Product Details
Author: Dario Ribero ,
Timothy M Pawlik
Publisher: Nova Science Publishers Inc
Imprint: Nova Science Publishers Inc
Weight: 0.990kg
ISBN: 9781634834889
ISBN 10: 1634834887
Pages: 417
Publication Date: 01 December 2015
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Author Information
Dario Ribero was born and raised in Torino, Italy. After completing his studies of medicine in 1999 at the University of Torino, he did his residency in General Surgery at the Mauriziano Hospital, Department of Hepato-Biliary-Pancreatic and Digestive Surgery, in Torino. From 2005 to 2007 he did a research fellowship at the Department of Surgical Oncology, Liver Unit, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA. After this experience he worked at the Mauriziano Hospital in Turin, Division of Surgical Oncology and General Surgery. In 2014 he moved to the European Institute of Oncology in Milan, Italy, where he is the Director of the Division of Hepatobilio-Pancreatic Surgery. His area of expertise is the hepato-biliary surgery with a particular interest in the multi-disciplinary management of liver metastasis of colorectal cancer as well as bile duct and gallbladder cancer. Since 2007 he is a faculty of the Italian School of hepatic surgery endorsed by the ACOI (Associazione Italiana Chirurghi Ospedalieri). Dr Ribero is also a member of the I.H.P.B.A. (International Hepato-Pancreato-Biliary Association) and of the ACOI and Member of the Advisory Board of the ESDO (European Society of Digestive Oncology).
